Evidence map›Paper›PMID 33466640›Full record

ArticleInternational journal of molecular sciences2021

The

Renátó Kovács, Fruzsina Nagy, Zoltán Tóth, Lajos Forgács, Liliána Tóth, Györgyi Váradi, Gábor K Tóth, Karina Vadászi, Andrew M Borman, László Majoros and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Morphotype-specific susceptibility toMicrobiology spectrum · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Innovative antifungal strategies to combat drug-resistantFrontiers in cellular and infection microbiology · 2025
    Review
  8. Article
  9. Current Perspectives of Antifungal Therapy: A Special Focus onJournal of fungi (Basel, Switzerland) · 2024
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Soil-BorneInternational journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Renátó KovácsDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.ORCID 0000-0003-3946-2424
Fruzsina NagyDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
Zoltán TóthDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
Lajos ForgácsDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
Liliána TóthInstitute of Plant Biology, Biological Research Centre, Temesvári krt. 62, 6726 Szeged, Hungary.
Györgyi VáradiDepartment of Medical Chemistry, Faculty of Medicine, University of Szeged, Dóm tér 8, 6720 Szeged, Hungary.
Gábor K TóthDepartment of Medical Chemistry, Faculty of Medicine, University of Szeged, Dóm tér 8, 6720 Szeged, Hungary.
Karina VadásziDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
Andrew M BormanUK National Mycology Reference Laboratory, Public Health England, Science Quarter, Southmead Hospital, Bristol BS10 5NB, UK.ORCID 0000-0003-0585-5721
László MajorosDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
László GalgóczyInstitute of Plant Biology, Biological Research Centre, Temesvári krt. 62, 6726 Szeged, Hungary.ORCID 0000-0002-6976-8910
University of Debrecen · HUUniversity of Szeged · HUUniversity of Exeter · GB

Funding

FEMS FEMS-GO-2019-502Hungarian National Research, Development and Innovation (NKFIH) Office ANN 131341Hungarian National Research, Development and Innovation (NKFIH) Office GINOP-2.3.2-15-2016-00014Hungarian National Research, Development and Innovation (NKFIH) Office GINOP-2.3.4-15-2020-00008Hungarian National Research, Development and Innovation (NKFIH) Office OTKA Bridging FundMinistry of Human Capacities EFOP-3.6.3-VEKOP-16-2017-00009Ministry of Human Capacities ÚNKP-19-3Ministry of Human Capacities ÚNKP-20-3New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund ÚNKP-20-5the Ministry of Human Capacities TKP-2020
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsBiofilmsCandidaCandidiasisDrug Resistance, MultipleDrug SynergismFungal ProteinsHumansNeosartoryaAntifungal AgentsFungal Proteinsantifungal lock therapyantifungal susceptibility testingbiofilmCandida aurisdrug–drug interactionNFAP2

Identifiers

PMID33466640
PMCPMC7828714
OpenAlexW3119269296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.